{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T06:07:06Z","timestamp":1778220426948,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Study on mechanism of Xin 'an Medical Gubenpeiyuan prescription treating Wilson's disease based on enterohepatic axis and enterobrain axis pathway","award":["No. U22A20366)"],"award-info":[{"award-number":["No. U22A20366)"]}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"crossref","award":["No.2023ZD0505801"],"award-info":[{"award-number":["No.2023ZD0505801"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04619-1","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:17:26Z","timestamp":1769105846000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A type IV spinal muscular atrophy with gastrocnemius pseudohypertrophy caused by SMN1 deletion: a case report and literature review"],"prefix":"10.1186","volume":"26","author":[{"given":"Hu","family":"Xi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wangsheng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenting","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Diao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"4619_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-022-00380-8","volume":"8 1","author":"E Mercuri","year":"2022","unstructured":"Mercuri E, Sumner CJ, Muntoni F, Darras BT, Finkel RS. Spinal muscular atrophy. Nat Reviews Disease Primers. 2022;8 1:52. https:\/\/doi.org\/10.1038\/s41572-022-00380-8.","journal-title":"Nat Reviews Disease Primers"},{"issue":"1","key":"4619_CR2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13023-017-0671-8","volume":"12","author":"IEC Verhaart","year":"2017","unstructured":"Verhaart IEC, Robertson A, Wilson IJ, Aartsma-Rus A, Cameron S, Jones CC, et al Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy-a literature review. Orphanet J Rare Dis. 2017;12(1):124. https:\/\/doi.org\/10.1186\/s13023-017-0671-8.","journal-title":"Orphanet J Rare Dis"},{"key":"4619_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/ijms241511939","volume":"24","author":"H Nishio","year":"2023","unstructured":"Nishio H, Niba ETE, Saito T, Okamoto K, Takeshima Y, Awano H. Spinal muscular atrophy: the Past, Present, and future of diagnosis and treatment. Int J Mol Sci. 2023;24:15. https:\/\/doi.org\/10.3390\/ijms241511939.","journal-title":"Int J Mol Sci"},{"key":"4619_CR4","doi-asserted-by":"publisher","first-page":"E448","DOI":"10.1097\/bsd.0000000000000968","volume":"33 10","author":"S Niu","year":"2020","unstructured":"Niu S, Anastasio AT, Maidman SD, Faraj RR, Rhee JM. The frequency of various myelopathic symptoms in cervical myelopathy: evaluation in a large surgical cohort. Clin Spine Surg. 2020;33 10:E448\u201353. https:\/\/doi.org\/10.1097\/bsd.0000000000000968.","journal-title":"Clin Spine Surg"},{"key":"4619_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","volume":"28 2","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M, et al. Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disorders: NMD. 2018;28 2:103\u201315. https:\/\/doi.org\/10.1016\/j.nmd.2017.11.005.","journal-title":"Neuromuscul Disorders: NMD"},{"key":"4619_CR6","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1038\/s41436-020-00961-6","volume":"23 12","author":"JL Deignan","year":"2021","unstructured":"Deignan JL, Astbury C, Behlmann A, Guha S, Monaghan KG, Reddi HV, et al. Addendum: technical standards and guidelines for spinal muscular atrophy testing. Genet Medicine: Official J Am Coll Med Genet. 2021;23 12:2462. https:\/\/doi.org\/10.1038\/s41436-020-00961-6.","journal-title":"Genet Medicine: Official J Am Coll Med Genet"},{"issue":"11","key":"4619_CR7","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1002\/acn3.51889","volume":"10","author":"CM De Proud","year":"2023","unstructured":"Proud CM, Mercuri E, Finkel RS, Kirschner J, De Vivo DC, Muntoni F, et al Combination disease-modifying treatment in spinal muscular atrophy: a proposed classification. Ann Clin Transl Neurol. 2023;10(11):2155\u201360. https:\/\/doi.org\/10.1002\/acn3.51889.","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"4619_CR8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, B\u00fcrglen L, Reboullet S, Clermont O, Burlet P, Viollet L, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995;80(1):155\u201365. https:\/\/doi.org\/10.1016\/0092-8674(95)90460-3.","journal-title":"Cell"},{"key":"4619_CR9","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.2353\/ajpath.2007.070399","volume":"171 4","author":"J Vitte","year":"2007","unstructured":"Vitte J, Fassier C, Tiziano FD, Dalard C, Soave S, Roblot N, et al. Refined characterization of the expression and stability of the SMN gene products. Am J Pathol. 2007;171 4:1269\u201380. https:\/\/doi.org\/10.2353\/ajpath.2007.070399.","journal-title":"Am J Pathol"},{"key":"4619_CR10","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.4103\/0366-6999.247198","volume":"131 24","author":"YY Cao","year":"2018","unstructured":"Cao YY, Zhang WH, Qu YJ, Bai JL, Jin YW, Wang H, et al. Diagnosis of spinal muscular atrophy: A simple method for quantifying the relative amount of survival motor neuron gene 1\/2 using Sanger DNA sequencing. Chin Med J. 2018;131 24:2921\u20139. https:\/\/doi.org\/10.4103\/0366-6999.247198.","journal-title":"Chin Med J"},{"issue":"2","key":"4619_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3233\/jnd-200475","volume":"7","author":"W M\u00fcller-Felber","year":"2020","unstructured":"M\u00fcller-Felber W, Vill K, Schwartz O, Gl\u00e4ser D, Nennstiel U, Wirth B, et al. Infants diagnosed with spinal muscular atrophy and 4 SMN2 copies through newborn Screening - Opportunity or burden? J Neuromuscul Dis. 2020;7(2):109\u201317. https:\/\/doi.org\/10.3233\/jnd-200475.","journal-title":"J Neuromuscul Dis"},{"key":"4619_CR12","doi-asserted-by":"publisher","first-page":"1307636","DOI":"10.3389\/fncel.2023.1307636","volume":"17","author":"S Rashid","year":"2023","unstructured":"Rashid S, Dimitriadi M. Autophagy in spinal muscular atrophy: from pathogenic mechanisms to therapeutic approaches. Front Cell Neurosci. 2023;17:1307636. https:\/\/doi.org\/10.3389\/fncel.2023.1307636.","journal-title":"Front Cell Neurosci"},{"key":"4619_CR13","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.jmoldx.2020.03.001","volume":"22 6","author":"J Zhang","year":"2020","unstructured":"Zhang J, Wang Y, Ma D, Sun Y, Li Y, Yang P, et al. Carrier screening and prenatal diagnosis for spinal muscular atrophy in 13,069 Chinese pregnant women. J Mol Diagnostics: JMD. 2020;22 6:817\u201322. https:\/\/doi.org\/10.1016\/j.jmoldx.2020.03.001.","journal-title":"J Mol Diagnostics: JMD"},{"key":"4619_CR14","doi-asserted-by":"publisher","first-page":"e18975","DOI":"10.1097\/md.0000000000018975","volume":"99 5","author":"C Li","year":"2020","unstructured":"Li C, Geng Y, Zhu X, Zhang L, Hong Z, Guo X, et al. The prevalence of spinal muscular atrophy carrier in china: evidences from epidemiological surveys. Medicine. 2020;99 5:e18975. https:\/\/doi.org\/10.1097\/md.0000000000018975.","journal-title":"Medicine"},{"key":"4619_CR15","doi-asserted-by":"publisher","first-page":"e2103","DOI":"10.1212\/wnl.0000000000207878","volume":"101 21","author":"V Aponte Ribero","year":"2023","unstructured":"Aponte Ribero V, Mart\u00ed Y, Batson S, Mitchell S, Gorni K, Gusset N, et al. Systematic literature review of the natural history of spinal muscular atrophy: motor Function, Scoliosis, and contractures. Neurology. 2023;101 21:e2103\u201313. https:\/\/doi.org\/10.1212\/wnl.0000000000207878.","journal-title":"Neurology"},{"issue":"1","key":"4619_CR16","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/ped.14047","volume":"62","author":"H Kitaoka","year":"2020","unstructured":"Kitaoka H, Shitara Y, Uchida Y, Kondo U, Omori I. Case of spinal muscular atrophy type 0 with mild prognosis. Pediatr Int. 2020;62(1):106\u20137. https:\/\/doi.org\/10.1111\/ped.14047.","journal-title":"Pediatr Int"},{"key":"4619_CR17","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1080\/09593985.2023.2164842","volume":"40 6","author":"A Kahraman","year":"2024","unstructured":"Kahraman A, Mutlu A, Livanelio\u011flu A. General movements in spinal muscular atrophy type 1. Physiother Theory Pract. 2024;40 6:1249\u201355. https:\/\/doi.org\/10.1080\/09593985.2023.2164842.","journal-title":"Physiother Theory Pract"},{"key":"4619_CR18","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1002\/ana.25900","volume":"88 6","author":"G Coratti","year":"2020","unstructured":"Coratti G, Messina S, Lucibello S, Pera MC, Montes J, Pasternak A, et al. Clinical variability in spinal muscular atrophy type III. Ann Neurol. 2020;88 6:1109\u201317. https:\/\/doi.org\/10.1002\/ana.25900.","journal-title":"Ann Neurol"},{"issue":"2","key":"4619_CR19","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/ene.14587","volume":"28","author":"PVS Souza","year":"2021","unstructured":"Souza PVS, Pinto W, Ricarte A, Badia BML, Seneor DD, Teixeira DT, et al. Clinical and radiological profile of patients with spinal muscular atrophy type 4. Eur J Neurol. 2021;28(2):609\u201319. https:\/\/doi.org\/10.1111\/ene.14587.","journal-title":"Eur J Neurol"},{"issue":"9","key":"4619_CR20","doi-asserted-by":"publisher","first-page":"4583","DOI":"10.1007\/s10072-024-07613-6","volume":"45","author":"DK Nurputra","year":"2024","unstructured":"Nurputra DK, Sofian J, Iskandar K, Triono A, Herini ES, Sunartini, et al. Multidisciplinary approach on divergent outcomes in spinal muscular atrophies: comparing DYNC1H1 and SMN1 gene mutations. Neurol sciences: official J Italian Neurol Soc Italian Soc Clin Neurophysiol. 2024;45(9):4583\u20138. https:\/\/doi.org\/10.1007\/s10072-024-07613-6.","journal-title":"Neurol sciences: official J Italian Neurol Soc Italian Soc Clin Neurophysiol"},{"issue":"1","key":"4619_CR21","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12883-023-03260-0","volume":"23","author":"H Chen","year":"2023","unstructured":"Chen H, Sun C, Zheng Y, Yin J, Gao M, Zhao C, et al. A TRPV4 mutation caused Charcot-Marie-Tooth disease type 2 C with scapuloperoneal muscular atrophy overlap syndrome and scapuloperoneal spinal muscular atrophy in one family: a case report and literature review. BMC Neurol. 2023;23(1):250. https:\/\/doi.org\/10.1186\/s12883-023-03260-0.","journal-title":"BMC Neurol"},{"issue":"1","key":"4619_CR22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13018-022-02996-8","volume":"17","author":"N Salari","year":"2022","unstructured":"Salari N, Fatahi B, Valipour E, Kazeminia M, Fatahian R, Kiaei A, et al Global prevalence of Duchenne and Becker muscular dystrophy: a systematic review and meta-analysis. J Orthop Surg Res. 2022;17(1):96. https:\/\/doi.org\/10.1186\/s13018-022-02996-8.","journal-title":"J Orthop Surg Res"},{"key":"4619_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","volume":"7 1","author":"D Duan","year":"2021","unstructured":"Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A. Duchenne muscular dystrophy. Nat Reviews Disease Primers. 2021;7 1:13. https:\/\/doi.org\/10.1038\/s41572-021-00248-3.","journal-title":"Nat Reviews Disease Primers"},{"key":"4619_CR24","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/s1474-4422(20)30028-4","volume":"19 6","author":"R Thompson","year":"2020","unstructured":"Thompson R, Spendiff S, Roos A, Bourque PR, Warman Chardon J, Kirschner J, et al. Advances in the diagnosis of inherited neuromuscular diseases and implications for therapy development. Lancet Neurol. 2020;19 6:522\u201332. https:\/\/doi.org\/10.1016\/s1474-4422(20)30028-4.","journal-title":"Lancet Neurol"},{"key":"4619_CR25","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1097\/phm.0000000000001500","volume":"99 12","author":"M Rodr\u00edguez-Cruz","year":"2020","unstructured":"Rodr\u00edguez-Cruz M, Almeida-Becerril T, Atilano-Miguel S, C\u00e1rdenas-Conejo A, Bernabe-Garc\u00eda M. Natural history of serum enzyme levels in Duchenne muscular dystrophy and implications for clinical practice. Am J Phys Med Rehabil. 2020;99 12:1121\u20138. https:\/\/doi.org\/10.1097\/phm.0000000000001500.","journal-title":"Am J Phys Med Rehabil"},{"key":"4619_CR26","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.nmd.2023.12.007","volume":"34","author":"L Benarroch","year":"2024","unstructured":"Benarroch L, Bonne G, Rivier F, Hamroun D. The 2024 version of the gene table of neuromuscular disorders (nuclear genome). Neuromuscul Disorders: NMD. 2024;34:126\u201370. https:\/\/doi.org\/10.1016\/j.nmd.2023.12.007.","journal-title":"Neuromuscul Disorders: NMD"},{"key":"4619_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/s1474-4422(23)00419-2","volume":"23 2","author":"CJJ Yeo","year":"2024","unstructured":"Yeo CJJ, Tizzano EF, Darras BT. Challenges and opportunities in spinal muscular atrophy therapeutics. Lancet Neurol. 2024;23 2:205\u201318. https:\/\/doi.org\/10.1016\/s1474-4422(23)00419-2.","journal-title":"Lancet Neurol"},{"issue":"4","key":"4619_CR28","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/s1474-4422(21)00001-6","volume":"20","author":"JW Day","year":"2021","unstructured":"Day JW, Finkel RS, Chiriboga CA, Connolly AM, Crawford TO, Darras BT, et al. Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial. Lancet Neurol. 2021;20(4):284\u201393. https:\/\/doi.org\/10.1016\/s1474-4422(21)00001-6.","journal-title":"Lancet Neurol"},{"key":"4619_CR29","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s13311-020-01004-3","volume":"18 2","author":"SA Rudnicki","year":"2021","unstructured":"Rudnicki SA, Andrews JA, Duong T, Cockroft BM, Malik FI, Meng L, et al. Reldesemtiv in patients with spinal muscular atrophy: a phase 2 Hypothesis-Generating study. Neurotherapeutics: J Am Soc Experimental Neurother. 2021;18 2:1127\u201336. https:\/\/doi.org\/10.1007\/s13311-020-01004-3.","journal-title":"Neurotherapeutics: J Am Soc Experimental Neurother"},{"key":"4619_CR30","doi-asserted-by":"publisher","first-page":"e209151","DOI":"10.1212\/wnl.0000000000209151","volume":"102 5","author":"TO Crawford","year":"2024","unstructured":"Crawford TO, Darras BT, Day JW, Dunaway Young S, Duong T, Nelson LL, et al. Safety and efficacy of apitegromab in patients with spinal muscular atrophy types 2 and 3: the phase 2 TOPAZ study. Neurology. 2024;102 5:e209151. https:\/\/doi.org\/10.1212\/wnl.0000000000209151.","journal-title":"Neurology"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04619-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04619-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04619-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T17:07:39Z","timestamp":1771434459000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-025-04619-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4619"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04619-1","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"23 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This manuscript strictly follows the declaration of Helsinki, etc. The review opinion of the Medical ethics committee of The first affiliated hospital of Anhui university of Chinese Medicine(Anhui Provincial Hospital of Chinese Medicine): Based on international ethical standards and Chinese laws and regulations, case reports are not classified as clinical studies and, consequently, do not necessitate ethical review. Therefore, this case report was exempt from ethical. Written informed consent has been provided by the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient has granted written informed consent for the publication of this case report and any associated photos.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"111"}}